retatrutide weight loss clinical Triple hormone receptor agonist for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial Retatrutide, an investigational triple hormone
Description
Conflict of interest The authors declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest
New England Journal of Medicine , 387 (3), 205-216
This mom has been struggling with weight loss for years
Scrambled or soft-boiled eggs are particularly well tolerated
Concurrent use is not recommended because both drugs act on the GLP-1 receptor simultaneously, increasing nausea and GI side effect risk significantly
